Aigen Investment Management, LP Mirum Pharmaceuticals, Inc. Transaction History
Aigen Investment Management, LP
- $533 Million
- Q4 2024
A detailed history of Aigen Investment Management, LP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Aigen Investment Management, LP holds 7,742 shares of MIRM stock, worth $395,306. This represents 0.06% of its overall portfolio holdings.
Number of Shares
7,742Holding current value
$395,306% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
196Shares Held
54.2MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$335 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$229 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$176 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$165 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$157 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.88B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...